Pain Medicine, Interventional Pain Medicine · Tulsa, OK
NPI
1912030404
Since 2007
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
7901 S Sheridan Rd
Tulsa, OK, 74133
Phone (918) 710-4112
Groups this clinician bills Medicare through
Medicare paid, 2024
$579K
16,719 services
Medicare patients, 2024
1,001
Average age 69
Drug cost, 2024
$1.1M
19,214 prescriptions
Company payments, 2025
$154
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank J Hackl was code 80307 (drug tests), 2,401 times for 815 patients. In total Frank J Hackl billed 16,719 services in 84 codes, and Medicare paid $579K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80307 Drug Tests | Office | 2,401 | 815 | $59.72 | $143K |
| 96127 Behavioral Health Services | Office | 2,089 | 761 | $2.61 | $5,447 |
| 99213 Office E&M - Established | Office | 1,906 | 746 | $52.40 | $100K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 909 | 509 | $193.57 | $176K |
| 99214 Office E&M - Established | Office | 627 | 413 | $75.53 | $47K |
| 99406 Behavioral Health Services | Office | 270 | 136 | $12.02 | $3,246 |
| 85025 Blood Count | Office | 197 | 187 | $7.57 | $1,492 |
| 83036 Blood Count | Office | 183 | 179 | $9.44 | $1,728 |
| 84132 Clinical Chemistry | Office | 161 | 161 | $4.66 | $750 |
| 82247 Clinical Chemistry | Office | 161 | 161 | $4.92 | $792 |
| 82310 Clinical Chemistry | Office | 161 | 161 | $5.06 | $815 |
| 82565 Clinical Chemistry | Office | 161 | 161 | $5.02 | $808 |
| 84075 Clinical Chemistry | Office | 161 | 161 | $5.08 | $818 |
| 82947 Clinical Chemistry | Office | 160 | 160 | $3.85 | $616 |
| 84450 Clinical Chemistry | Office | 160 | 160 | $5.08 | $813 |
By year: 2022 $1.3M for 30,007 services; 2023 $450K for 11,089 services; 2024 $579K for 16,719 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 2,401 | 815 | $59.72 | $143K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 909 | 509 | $193.57 | $176K |
| 85025 Blood Count | 197 | 187 | $7.57 | $1,492 |
| 83036 Blood Count | 183 | 179 | $9.44 | $1,728 |
| 84075 Clinical Chemistry | 161 | 161 | $5.08 | $818 |
| 82247 Clinical Chemistry | 161 | 161 | $4.92 | $792 |
| 82310 Clinical Chemistry | 161 | 161 | $5.06 | $815 |
| 82565 Clinical Chemistry | 161 | 161 | $5.02 | $808 |
| 84132 Clinical Chemistry | 161 | 161 | $4.66 | $750 |
| 82435 Clinical Chemistry | 160 | 160 | $4.51 | $722 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank J Hackl prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 4,204 prescriptions and refills. In total Frank J Hackl wrote 19,214 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 4,204 | 4,221 | 548 | $134K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,538 | 2,543 | 335 | $79K |
| Gabapentin Generic | 1,593 | 1,731 | 218 | $20K |
| Pregabalin Generic | 929 | 978 | 135 | $16K |
| Morphine Sulfate Er Morphine Sulfate | 919 | 920 | 113 | $20K |
| Tizanidine Hcl Generic | 854 | 910 | 112 | $9,238 |
| Cyclobenzaprine Hcl Generic | 778 | 861 | 116 | $8,289 |
| Oxycodone Hcl Generic | 619 | 619 | 102 | $9,568 |
| Tramadol Hcl Er Tramadol Hcl | 504 | 504 | 60 | $32K |
| Baclofen Generic | 478 | 490 | 66 | $4,917 |
| Meloxicam Generic | 466 | 494 | 74 | $1,155 |
| Tramadol Hcl Generic | 461 | 463 | 84 | $4,666 |
| Diclofenac Sodium Generic | 402 | 445 | 67 | $6,244 |
| Buprenorphine Generic | 341 | 341 | 91 | $90K |
| Morphine Sulfate Generic | 267 | 267 | 37 | $7,696 |
Brand drugs: 1,186 claims; generic drugs: 18,028 claims; opioid claims: 10,567.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank J Hackl $154 ($154 in general payments such as food, travel and fees) from 6 companies. The largest payer was Collegium Pharmaceutical, Inc. with $34.89.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.